Earnings Feed
Start Free
Home/Filings/4/0001855763-23-000009
4//SEC Filing

Carle Vanessa 4

Accession 0001855763-23-000009

CIK 0001348362other
View on SEC.govCompany Profile

Filed

Oct 31, 8:00 PM ET

Accepted

Nov 1, 1:45 PM ET

Size

12.3 KB

Accession

0001855763-23-000009

Insider Transaction Report

Form 4
Period: 2023-10-26
Lexaria Bioscience Corp.LEXX
Carle Vanessa
Secretary
Transactions
  • Award

    Stock Options

    2023-10-26+12,500→ 52,567 total
    Exercise: $1.15From: 2023-10-26Exp: 2028-10-26→ Common Shares (12,500 underlying)
Holdings

  • Stock Options

    Exercise: $3.00From: 2021-04-26Exp: 2026-04-26→ Common Shares (12,500 underlying)
    12,567

  • Warrants

    Exercise: $36.00From: 2019-11-13Exp: 2024-11-13→ Common Shares (67 underlying)
    67

  • Stock Options

    Exercise: $3.00From: 2021-06-08Exp: 2026-06-08→ Common Shares (5,000 underlying)
    17,567

  • common shares

    67

  • Stock Options

    Exercise: $3.00From: 2021-09-01Exp: 2026-09-01→ Common Shares (10,000 underlying)
    27,567

  • Stock Options

    Exercise: $2.91From: 2022-08-29Exp: 2027-08-29→ Common Shares (12,500 underlying)
    40,067
Footnotes (3)
  • [F1]Repriced from $5.31 pursuant to shareholder approval received on May 9, 2023
  • [F2]Repriced from $7.08 pursuant to shareholder approval received on May 9, 2023
  • [F3]Repriced from $6.23 pursuant to shareholder approval received on May 9, 2023

Documents

1 file

Issuer

Lexaria Bioscience Corp.

CIK 0001348362

→
Entity typeother

Related Parties

1
  • filerCIK 0001855763

Filing Metadata

Form type
4
Filed
Oct 31, 8:00 PM ET
Accepted
Nov 1, 1:45 PM ET
Size
12.3 KB
View on SEC.gov